screen_shot_2014-01-21_at_08

Novasep adds president to complete its executive team

pharmafile | January 21, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nieuwenhove, Novasep 

Thierry Van Nieuwenhove has joined contract manufacturing organisation Novasep as president of its Synthesis business unit.

Educated as a bio-engineer, Van Nieuwenhove, 40, joins Novasep from Ajinomoto-Omnichem, a European synthetic molecules firm owned by a Japanese company, where he held consecutive positions as director, then general manager and member of the board. 

“We are thrilled to welcome Thierry to Novasep as president of the Synthesis business unit,” said Michel Spagnol, chief executive of Novasep. “Thierry possesses the dynamics to boost Novasep’s CMO business in all our key markets.”

Advertisement

“I am very pleased to join Novasep,” added Van Nieuwenhove. “The group as a whole has tremendous opportunities to develop. Really innovative solutions can come out from the cross-fertilisation of its several specialised technologies and application markets that will build future Novasep expertise. I am excited to be part of it.”

Related Content

AZ image

AstraZeneca sets up production unit in Africa

AstraZeneca is embarking upon a joint venture that will involve the building of a new …

lonza image

Lonza earmarks $15m for ADC plant expansion

Swiss contract manufacturer Lonza has said it will invest around 14 million francs ($15m) in …

Novasep invest €30m in ‘world’s largest chromatography plant’

French purification specialist Novasep has said it plans to invest €30 million in a new …

The Gateway to Local Adoption Series

Latest content